Press Releases By Samaritan Pharmaceuticals

• [Medical] Samaritan Licenses Exclusive Rights to Infectious Disease Compounds From Georgetown University
• [Medical] Shire Human Genetic Therapies AB Signs Exclusive Marketing and Distribution Deal with Samaritan to Launch REPLAGAL® for Fabry Disease in Greece and Cyprus